ALX-0651
ALX-0651 is a biparatopic humanized monoclonal antibody inhibitor targeting CXCR4. ALX-0651 inhibits hematopoietic stem cell trafficking, tumor progression and metastasis. ALX-0651 can be used for non-Hodgkin’s lymphoma and multiple myeloma research[1].
Product Specifications
UNSPSC
12352100
Target
CXCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]De Pauw T, et al. Current status and future expectations of nanobodies in oncology trials. Expert Opin Investig Drugs. 2023 Jul-Dec;32 (8) :705-721.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CXCR4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-14048CL1 0.1 mL
Rabbit Monoclonal SLC45A3/Prostein Antibody (SLC45A3/4965R) [CoraFluor 1]
Ask
View Details